Teva Pharmaceutical Industries Limited (TEVA) Earnings History
Profitable35 years of earnings data (1991–2025) · Positive TTM net income
Loading earnings history...
Teva Pharmaceutical Industries Limited (TEVA) Earnings Overview
As of June 22, 2026, Teva Pharmaceutical Industries Limited (TEVA) reported trailing twelve-month net income of $1.56B, reflecting +182.8% year-over-year growth. The company earned $1.33 per diluted share over the past four quarters, with a net profit margin of 8.2%.
Looking at the long-term picture, TEVA's historical earnings data spans multiple years. The company achieved its highest annual net income of $3.33B in fiscal 2010.
Teva Pharmaceutical Industries Limited maintains positive profitability with a gross margin of 51.8%, operating margin of 12.5%, and net margin of 8.2%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including VTRS (-$296M net income, -24.6% margin), PRGO (-$1.82B net income, -33.5% margin), AMRX ($72M net income, 2.4% margin), TEVA has outperformed on profitability metrics. Compare TEVA vs VTRS →
TEVA Earnings vs Peers
Earnings metrics vs comparable public companies
TEVA Historical Earnings Data (1991–2025)
35 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.41B | +186.0% | $2.16B | $1.20 | 8.2% | 12.5% |
| 2024 | -$1.64B | -193.2% | -$303M | $-1.45 | -9.9% | -1.8% |
| 2023 | -$559M | +77.1% | $433M | $-0.50 | -3.5% | 2.7% |
| 2022 | -$2.45B | -686.6% | -$2.20B | $-2.20 | -16.4% | -14.7% |
| 2021 | $417M | +110.5% | $1.72B | $0.38 | 2.6% | 10.8% |
| 2020 | -$3.99B | -299.4% | -$3.57B | $-3.64 | -24.0% | -21.4% |
| 2019 | -$999M | +53.5% | -$443M | $-0.92 | -5.9% | -2.6% |
| 2018 | -$2.15B | +86.8% | -$1.64B | $-2.11 | -11.4% | -8.7% |
| 2017 | -$16.27B | -5043.8% | -$17.48B | $-16.01 | -72.7% | -78.1% |
| 2016 | $329M | -79.3% | $2.15B | $0.07 | 1.5% | 9.8% |
| 2015 | $1.59B | -48.0% | $3.35B | $1.82 | 8.1% | 17.1% |
| 2014 | $3.06B | +140.7% | $3.95B | $3.56 | 15.1% | 19.5% |
| 2013 | $1.27B | -35.4% | $1.65B | $1.49 | 6.2% | 8.1% |
| 2012 | $1.96B | -28.9% | $2.21B | $2.25 | 9.7% | 10.9% |
| 2011 | $2.76B | -17.2% | $3.11B | $3.09 | 15.1% | 17.0% |
| 2010 | $3.33B | +66.5% | $3.87B | $3.67 | 20.7% | 24.0% |
| 2009 | $2.00B | +215.0% | $2.40B | $2.23 | 14.4% | 17.3% |
| 2008 | $635M | -67.5% | $1.15B | $0.78 | 5.7% | 10.3% |
| 2007 | $1.95B | +257.5% | $2.40B | $2.38 | 20.7% | 25.5% |
| 2006 | $546M | -49.1% | $801M | $0.69 | 6.5% | 9.5% |
| 2005 | $1.07B | +223.2% | $1.31B | $1.59 | 20.4% | 25.0% |
| 2004 | $332M | -52.0% | $578M | $0.50 | 6.9% | 12.0% |
| 2003 | $691M | +68.4% | $877M | $1.20 | 21.1% | 26.8% |
| 2002 | $410M | +47.5% | $524M | $0.76 | 16.3% | 20.8% |
| 2001 | $278M | +87.5% | $361M | $0.51 | 13.4% | 17.4% |
| 2000 | $148M | +26.0% | $245M | $0.28 | 8.5% | 14.0% |
| 1999 | $118M | +71.3% | $199M | $0.24 | 9.2% | 15.5% |
| 1998 | $69M | -32.2% | $145M | $0.14 | 6.2% | 13.0% |
| 1997 | $102M | +38.3% | $174M | $0.21 | 9.1% | 15.6% |
| 1996 | $73M | -8.0% | $129M | $0.15 | 7.7% | 13.6% |
| 1995 | $80M | +11.5% | $115M | $0.14 | 12.0% | 17.3% |
| 1994 | $72M | +24.5% | $107M | $0.14 | 12.2% | 18.2% |
| 1993 | $58M | +76.4% | $88M | $0.14 | 11.5% | 17.5% |
| 1992 | $33M | +37.6% | $56M | $0.08 | 8.0% | 13.8% |
| 1991 | $24M | - | $52M | $0.06 | 7.2% | 15.9% |
Download Data
Export TEVA earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into TEVA consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
35+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TEVA — Frequently Asked Questions
Quick answers to the most common questions about buying TEVA stock.
What is TEVA earnings per share (EPS)?
TEVA trailing twelve-month (TTM) diluted EPS is $1.33, reflecting +182.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1991 to 2025 is available in the table on this page.
What is Teva Pharmaceutical Industries Limited's net income?
Teva Pharmaceutical Industries Limited (TEVA) trailing twelve-month net income is $1.6B as of 2025. Earnings grew +182.8% year-over-year.
Is TEVA profitable?
Yes, TEVA is profitable with a TTM net income of $1.6B and a net profit margin of +8.2%.
What is TEVA's earnings growth rate?
TEVA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: -4.1%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1991 to 2025.
What are TEVA's profit margins?
Teva Pharmaceutical Industries Limited net profit margin is +8.2%, operating margin is +12.5%, and gross margin is +51.8%. Margins are within a typical range for the sector. Return on Equity is +20.7%.
Is TEVA growing earnings?
Yes, TEVA earnings are accelerating — EPS growth of +182.8% exceeds the 5-year CAGR of N/A. TTM net income reached $1.6B. Earnings momentum is strengthening.
What was TEVA's best earnings year?
Teva Pharmaceutical Industries Limited's highest annual net income on record is $3.3B, achieved in fiscal year 2010. Earnings history on this page spans 1991 to 2025 and includes all annual and quarterly figures.
What were TEVA's earnings last quarter?
TEVA's most recent reported quarter was Q1 2026. Net income was $369M with diluted EPS of $0.31. For a full breakdown of all quarters, see the quarterly earnings table on this page.